Target intelligence / Profile preview

Intestinal epithelial cell surface glycans and mucus layer

Molecular classification
Glycoprotein, Mucin, Glycolipid, Polysaccharide, Extracellular matrix component
01

Overview

The intestinal epithelial cell surface glycans and mucus layer constitute a critical physiological barrier that separates the gut lumen from the underlying host tissue (Johansson et al., 2011, Nat Rev Gastroenterol Hepatol). This system is primarily composed of the gel-forming mucin MUC2, which creates a dense inner layer and a loose outer layer, along with the glycocalyx—a dense network of membrane-bound glycoproteins and glycolipids on the apical surface of enterocytes (Koropatkin et al., 2012, Nat Rev Microbiol). Biologically, this layer provides lubrication, prevents mechanical damage, and serves as a decoy and attachment site for both commensal and pathogenic microorganisms (Bansil & Turner, 2018, Curr Opin Colloid Interface Sci). In diseases such as ulcerative colitis and Crohn's disease, the integrity of this layer is often compromised, leading to increased permeability and chronic inflammation (Van der Post et al., 2019, Gastroenterology). Therapeutic strategies targeting this system include the use of mucosal protectants like rebamipide and sucralfate, as well as probiotics that stimulate mucin production to restore barrier function and promote mucosal healing (Ishihara & Tanaka, 2010, J Clin Biochem Nutr).

Other names
Intestinal mucus barrierIntestinal glycocalyxMucosal barrierEnterocyte surface glycansGut mucus layer
02

Mechanism of action

Stimulation of mucin synthesis and secretion, physical shielding of the mucosal surface from luminal aggressors, and modulation of glycan-mediated microbial adhesion (Ishihara & Tanaka, 2010, J Clin Biochem Nutr; McGuckin et al., 2011, Nat Rev Microbiol).

03

Biological functions

Physical barrierLubricationMicrobial colonization nicheImmune sequestrationCell signalingNutrient filtering
04

Disease associations

Inflammatory bowel diseaseUlcerative colitisCrohn's diseaseColorectal cancerEnteric infectionIrritable bowel syndromeCeliac disease
05

Safety considerations

Alteration of gut microbiota composition (dysbiosis)Potential for increased pathogen translocation if barrier integrity is compromisedInterference with nutrient absorptionSystemic absorption of normally excluded luminal toxins
06

Interacting drugs

Rebamipide

6 more in the full profile.

07

Biomarkers

Mucin 2 (MUC2)Trefoil factor 3 (TFF3)Fecal calprotectinZonulinIntestinal fatty acid binding protein (I-FABP)

Beyond the preview

Go deeper on Intestinal epithelial cell surface glycans and mucus layer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial cell surface glycans and mucus layer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call